Ronald Yanagihara

Zoledronic Acid Versus Placebo in the Treatment of Skeletal Metastases in Patients With Lung Cancer and Other Solid Tumors: A Phase III, Double-Blind, Randomized Trial—The Zoledronic Acid Lung Cancer and Other Solid Tumors Study Group

Lee S. Rosen, David Gordon, Simon Tchekmedyian et al. · Journal of Clinical Oncology · 2003 · 727 citations

Medicine, Oncology, Pharmacotherapy +17

Long‐term efficacy and safety of zoledronic acid in the treatment of skeletal metastases in patients with nonsmall cell lung carcinoma and other solid tumors

Lee S. Rosen, David Gordon, N. Simon Tchekmedyian et al. · Cancer · 2004 · 716 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial

Miguel Martín, Frankie A. Holmes, Bent Ejlertsen et al. · The Lancet Oncology · 2017 · 589 citations

Medicine, Oncology, Pharmacology +15

Nabiximols for Opioid-Treated Cancer Patients With Poorly-Controlled Chronic Pain: A Randomized, Placebo-Controlled, Graded-Dose Trial

Russell K. Portenoy, Elena Doina Ganae-Motan, Silvia Allende‐Pérez et al. · Journal of Pain · 2012 · 414 citations · Full text

Medicine, Oncology, Pharmacology +14

Multicenter Phase II Trial of S-1 Plus Cisplatin in Patients With Untreated Advanced Gastric or Gastroesophageal Junction Adenocarcinoma

Jaffer A. Ajani, Fa-Chyi Lee, D. A. Singh et al. · Journal of Clinical Oncology · 2006 · 92 citations · Full text

Medicine, Oncology, Pharmacotherapy +14